KERN - Akerna Corp Stock Price, Fair Value and News

1.60USD+0.10 (+6.67%)Delayed as of 26 Apr 2024, 11:05 am ET

Market Summary

USD1.60+0.10

Delayedas of 26 Apr 2024, 11:05 am

6.67%

KERN Stock Price

View Fullscreen

KERN RSI Chart

KERN Valuation

Market Cap

776.4K

Price/Earnings (Trailing)

-0.07

Price/Sales (Trailing)

0.11

EV/EBITDA

-0.04

Price/Free Cashflow

-0.13

KERN Price/Sales (Trailing)

KERN Profitability

Operating Margin

50.25%

EBT Margin

-298.92%

Return on Equity

128.49%

Return on Assets

-852.54%

Free Cashflow Yield

-758.41%

KERN Fundamentals

KERN Revenue

Revenue (TTM)

6.8M

Rev. Growth (Yr)

-32.04%

Rev. Growth (Qtr)

-8.97%

KERN Earnings

Earnings (TTM)

-11.6M

Earnings Growth (Yr)

86.42%

Earnings Growth (Qtr)

-32.05%

Breaking Down KERN Revenue

52 Week Range

1.60

(Low)(High)

Last 7 days

10.3%

Last 30 days

-24.3%

Last 90 days

-76.2%

Trailing 12 Months

-90.0%

How does KERN drawdown profile look like?

KERN Financial Health

Current Ratio

0.13

Debt/Equity

-0.09

Debt/Cashflow

-6.93

KERN Investor Care

Shares Dilution (1Y)

124.91%

Diluted EPS (TTM)

-31.61

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	12.3M	9.6M	8.2M	6.8M
2022	17.9M	16.4M	14.4M	13.6M
2021	14.8M	16.7M	18.2M	17.6M
2020	17.3M	12.6M	13.2M	13.9M
2019	9.8M	18.0M	18.9M	19.7M
2018	0	10.5M	10.1M	9.8M
2017	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Akerna Corp

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Oct 24, 2022	billingsley jessica	sold (taxes)	-	-	-2,371	chairman and ceo
Oct 21, 2022	sozio scott	acquired	-	-	125	head of cd
Oct 21, 2022	thompson cecil ray jr	acquired	-	-	375	chief operating officer
Oct 21, 2022	mccullough david r	acquired	-	-	350	chief technology officer
Oct 21, 2022	billingsley jessica	acquired	-	-	375	chairman and ceo
May 17, 2022	billingsley jessica	sold (taxes)	-	-	-6,743	chairman and ceo
Apr 25, 2022	fishman barry	acquired	-	-	3,486	-
Apr 25, 2022	kane matthew ryan	acquired	-	-	3,486	-
Apr 25, 2022	rehmatullah tahira	acquired	-	-	3,486	-
Apr 12, 2022	billingsley jessica	acquired	-	-	22,322	chairman and ceo

Which funds bought or sold KERN recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 09, 2024	American Capital Advisory, LLC	new	-	17.00	17.00	-%
Mar 11, 2024	VANGUARD GROUP INC	new	-	10,440	10,440	-%
Mar 01, 2024	GOLDMAN SACHS GROUP INC	added	100	1,115	2,324	-%
Mar 01, 2024	GOLDMAN SACHS GROUP INC	added	100	14,575	19,494	-%
Feb 26, 2024	Virtu Financial LLC	added	5.27	-	-	-%
Feb 15, 2024	JANE STREET GROUP, LLC	new	-	9,198	9,198	-%
Feb 14, 2024	SUSQUEHANNA INTERNATIONAL GROUP, LLP	new	-	107	107	-%
Feb 14, 2024	CITADEL ADVISORS LLC	new	-	47,024	47,024	-%
Feb 14, 2024	Royal Bank of Canada	reduced	-3.24	-	-	-%
Feb 14, 2024	SUSQUEHANNA INTERNATIONAL GROUP, LLP	unchanged	-	3,659	7,404	-%

Are Funds Buying or Selling KERN?

Are funds buying KERN calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own KERN

No. of Funds

Unveiling Akerna Corp's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 22, 2024	tolhurst daniel george	8.53%	3,309,649	SC 13G
Feb 16, 2024	chang robby sai kit	8.5%	3,309,648	SC 13D
Feb 16, 2024	rjl 18 capital canada lp	8.3%	3,201,399	SC 13G
Feb 16, 2024	roxy capital corp	8.5%	3,309,362	SC 13G
Jun 23, 2023	mj bridge co., inc.	14.78%	1e+06	SC 13G
May 07, 2021	blackrock inc.	4.9%	1,179,713	SC 13G/A
Feb 12, 2021	m&j special investments llc	4.3%	853,267	SC 13G/A
Feb 02, 2021	blackrock inc.	6.5%	1,278,795	SC 13G
Nov 13, 2020	poinsett amy a.	4.17%	821,552	SC 13G/A
Feb 13, 2020	m&j special investments llc	8.4%	917,253	SC 13G/A

Recent SEC filings of Akerna Corp

View All Filings

Date Filed	Form Type	Document
Apr 22, 2024	8-K	Current Report
Apr 19, 2024	424B5	Prospectus Filed
Apr 19, 2024	424B5	Prospectus Filed
Apr 19, 2024	8-K	Current Report
Apr 19, 2024	8-K	Current Report
Apr 18, 2024	S-3	S-3
Apr 08, 2024	4	Insider Trading
Apr 08, 2024	S-8	Employee Benefits Plan
Apr 03, 2024	EFFECT	EFFECT
Apr 01, 2024	10-K	Annual Report

Peers (Alternatives to Akerna Corp)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	455.4B	371.6B	0.35%	2.29%	20.35	1.23	14.64%	11.24%
CI	103.7B	195.3B	-0.89%	42.87%	19.3	0.53	8.17%	-20.79%
CVS	84.7B	357.8B	-15.14%	-6.85%	10.14	0.24	10.95%	93.52%
HCA	83.0B	65.0B	-4.22%	12.88%	15.84	1.28	7.86%	-7.11%
CNC	40.5B	154.0B	-2.44%	13.57%	14.98	0.26	6.54%	124.79%
DVA	11.6B	12.1B	-1.82%	53.92%	16.84	0.96	4.57%	23.40%
UHS	11.4B	14.3B	-6.87%	15.65%	15.95	0.8	6.59%	6.24%
MID-CAP
CHE	8.7B	2.3B	-10.00%	2.41%	31.81	3.83	6.06%	9.17%
ACHC	6.8B	2.9B	-4.41%	-0.94%	-312.56	2.31	12.20%	-107.93%
AMN	2.1B	3.8B	-9.00%	-34.66%	10.11	0.56	-27.73%	-52.50%
AMEH	2.0B	1.4B	-7.34%	3.16%	33.37	1.46	21.19%	34.42%
SMALL-CAP
ADUS	1.5B	1.1B	-10.65%	-18.57%	23.8	1.41	11.31%	35.83%
BKD	1.3B	3.0B	6.69%	62.95%	-6.87	0.43	6.74%	20.73%
BEAT	51.9M	-	-9.63%	1.03%	-3.54	-	-	-12.94%
AMS	19.7M	21.3M	20.46%	12.23%	37.05	0.93	8.00%	-62.25%

Akerna Corp News

Latest updates

Akerna Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2020Q1	2019Q4	2019Q3	2019Q2
Revenue	-100.0%	-	2,082,553	2,287,868	2,602,689	2,724,292	2,845,895	3,064,379	3,489,676	4,245,080	3,570,684	5,135,502	4,906,887	4,014,024	4,110,780	3,714,004	3,003,638	3,070,546	3,188,375	3,306,203	3,192,890	10,823,117
Cost Of Revenue	-57.7%	412,753	974,711	962,896	1,051,081	-	1,237,332	1,476,787	1,175,261	1,523,009	2,400,000	1,971,382	1,914,380	1,454,167	1,401,104	1,739,937	216,000	1,396,219	-	1,615,239	1,379,701	4,633,844
Gross Profit	-149.6%	-549,418	1,107,842	1,324,972	1,551,608	-	1,608,564	1,587,592	2,314,415	2,722,071	1,476,729	3,164,120	2,992,507	2,559,857	2,709,676	1,974,067	1,185,073	1,674,327	-	1,690,964	1,813,189	6,189,273
Operating Expenses	-97.7%	84,203	3,685,136	3,084,048	3,480,666	-	13,294,317	5,296,088	22,470,883	22,617,756	21,308,375	6,884,833	9,043,514	6,065,860	12,925,883	7,497,537	7,368,461	6,553,029	-	6,057,913	4,212,616	18,701,619
S&GA Expenses	-46.0%	305,771	566,147	650,358	781,491	-	1,068,189	954,759	1,979,091	2,051,133	2,143,746	2,002,461	1,826,143	1,735,915	1,830,526	2,097,502	2,117,118	2,040,751	-	4,883,172	3,601,714	57,999
R&D Expenses	-72.0%	181,775	649,070	659,287	845,478	-	740,662	959,186	1,275,372	1,715,747	1,374,186	1,566,478	1,527,258	1,424,100	1,407,262	1,758,826	1,088,938	874,787	-	623,501	610,902	2,687,228
EBITDA Margin	-26.5%	-2.87	-2.27	-2.10	-3.33	-4.35	-3.92	-4.21	-3.45	-2.40	-1.57	-1.19	-1.44	-1.60	-	-	-	-	-	-	-	-
Interest Expenses	941.0%	1,704,202	-202,644	-227,055	-487,316	-	865,590	-395,422	-212,987	-741	402,059	55,028	-725,327	776,181	153,687	-3,687	-155,027	33,522	-	51,857	73,382	39,602
Income Taxes	-	-	-	-	-	-	-448,003	-40,666	-128,042	-99,444	-2,274,295	-	4,300	6,270	-	-	30,985	-	-	-	-	-
Earnings Before Taxes	100.0%	-	-2,594,938	-3,081,951	-2,571,831	-	-12,186,668	-5,214,662	-20,629,610	-21,311,375	-19,238,361	-1,553,447	-6,097,169	-6,447,651	-12,219,944	-3,986,511	-6,026,430	-4,608,387	-	-3,763,695	-2,326,332	-
EBT Margin	-19.9%	-2.99	-2.49	-2.41	-3.72	-4.83	-4.35	-4.62	-3.82	-2.70	-1.89	-1.45	-1.72	-1.93	-	-	-	-	-	-	-	-
Net Income	-32.1%	-3,426,652	-2,594,938	-3,081,951	-2,474,628	-	-25,234,682	-2,304,088	-29,565,947	-21,952,893	-17,212,311	-1,553,447	-6,105,251	-6,457,702	792,357	-3,979,230	-5,312,523	-4,608,387	-	-3,763,695	-2,326,332	-12,403,215
Net Income Margin	58.4%	-1.69	-4.07	-3.46	-5.46	-6.44	-5.79	-4.94	-4.27	-2.62	-1.78	-0.73	-0.94	0.00	0.00	-	-	-	-	-	-	-
Free Cashflow	38.9%	-681,980	-1,115,744	-1,557,494	-2,542,136	-454,324	-454,324	-3,263,461	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																		(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q2
Assets	-67.5%	1.00	4.00	6.00	7.00	19.00	46.00	43.00	74.00	94.00	75.00	77.00	74.00	77.00	81.00	59.00	41.00	22.00	24.00
Current Assets	7.5%	1.00	1.00	2.00	3.00	15.00	13.00	9.00	15.00	18.00	14.00	16.00	20.00	23.00	19.00	28.00	18.00	22.00	24.00
Cash Equivalents	266.7%	1.00	0.00	1.00	1.00	1.00	9.00	5.00	10.00	13.00	10.00	12.00	16.00	18.00	15.00	25.00	15.00	19.00	22.00
Net PPE	-20.9%	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.00	1.00	1.00	1.00	-	0.00	-
Goodwill	-100.0%	-	1.00	2.00	2.00	2.00	9.00	9.00	30.00	33.00	14.00	47.00	5.00	42.00	47.00	20.00	3.00	17.00	-
Liabilities	-22.5%	10.00	13.00	15.00	13.00	24.00	25.00	30.00	34.00	35.00	10.00	15.00	15.00	20.00	24.00	23.00	-	-	5.00
Current Liabilities	-17.2%	10.00	13.00	12.00	11.00	23.00	20.00	22.00	30.00	29.00	6.00	13.00	13.00	16.00	18.00	12.00	5.00	3.00	2.00
Long Term Debt	-100.0%	-	1.00	2.00	2.00	1.00	5.00	7.00	2.00	4.00	4.00	1.00	-	4.00	-	-	-	-	-
LT Debt, Current	-33.4%	5.00	8.00	8.00	7.00	13.00	10.00	7.00	13.00	13.00	-	7.00	-	12.00	-	-	-	-	-
LT Debt, Non Current	-100.0%	-	1.00	2.00	2.00	1.00	5.00	7.00	2.00	4.00	4.00	1.00	-	4.00	-	-	-	-	-
Shareholder's Equity	-Infinity%	-9.01	-	-	-	-4.83	20.00	13.00	41.00	60.00	64.00	62.00	60.00	57.00	58.00	36.00	38.00	20.00	19.00
Retained Earnings	-2.0%	-179	-175	-173	-170	-167	-142	-140	-110	-88.51	-71.30	-69.74	-63.64	-57.18	-45.84	0.00	-38.10	-32.75	-27.58
Additional Paid-In Capital	-94.4%	9.00	164	163	162	160	160	150	149	146	133	124	111	94.00	83.00	72.00	70.00	52.00	46.00
Shares Outstanding	3.5%	1.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	41.00	60.00	-	-	60.00	57.00	-	36.00	-	-	19.00
Float	-	-	-	-	-	-	-	4,750,854	-	-	-	95.00	-	117	-	-	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	38.9%	-681	-1,115	-1,552	-2,537	-449	-3,263	-3,602	-3,585	-3,090	-1,362	-2,341	-1,373	-4,524	-4,181	-3,709	-3,913	-3,941	-3,142	-2,690	-2,868	-2,521
Share Based Compensation	-14.3%	86.00	100	108	109	177	220	173	304	486	510	571	503	433	764	459	302	331	161	-	-	-
Cashflow From Investing	-	637	-	-	600	-1,020	-1,586	-717	-647	-7,119	-1,361	-1,299	-704	-1,434	-5,704	-2,431	-557	270	-519	-	-	-
Cashflow From Financing	-	650	-	1,500	-4,917	17,131	-7,727	-761	-5.61	14,510	560	-	-333	9,545	-12.67	15,987	-	5.00	4,242	-	-	-

KERN Income Statement

2023-12-31

Consolidated Statements of Operations - USD ($)	12 Months Ended
Consolidated Statements of Operations - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Revenue
Total revenue	$ 6,836,444	$ 10,458,170
Cost of revenue	3,401,441	4,911,503
Gross profit	3,435,003	5,546,667
Operating expenses
Product development	2,335,609	4,088,294
Sales and marketing	2,293,767	5,572,721
General and administrative	5,677,485	8,018,255
Depreciation and amortization	27,191	4,421,995
Impairment of long-lived assets		26,528,630
Total operating expenses	10,334,052	48,629,895
Loss from operations	(6,899,049)	(43,083,228)
Other (expense) income
Interest expense, net	(1,130,343)	(853,566)
Change in fair value of convertible notes	(370,457)	(2,884,273)
Change in fair value of derivative liability		63,178
Other expense, net	(202,820)	(221,101)
Total other (expense) income	(1,703,620)	(3,895,762)
Net loss from continuing operations before income taxes	(8,602,669)	(46,978,990)
Income tax benefit on continuing operations		701,119
Net loss from continuing operations	(8,602,669)	(46,277,871)
Loss from discontinued operations, net of tax	(2,975,500)	(32,779,739)
Net loss	(11,578,169)	(79,057,610)
Deemed dividends related to convertible redeemable preferred stock		(955,500)
Net loss attributable to common stockholders	$ (11,578,169)	$ (80,013,110)
Basic weighted average common shares outstanding (in Shares)	371,020	146,393
Basic loss per common share from continuing operations (in Dollars per share)	$ (23.19)	$ (322.65)
Basic loss per common share from discontinued operations (in Dollars per share)	(8.02)	(223.92)
Basic loss per common share (in Dollars per share)	$ (31.21)	$ (546.56)
Software
Revenue
Total revenue	$ 6,787,285	$ 9,748,268
Consulting
Revenue
Total revenue	39,750	682,309
Other revenue
Revenue
Total revenue	$ 9,409	$ 27,593

KERN Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Current assets
Cash	$ 768,461	$ 877,844
Restricted cash		7,000,000
Accounts receivable, net	147,855	429,949
Prepaid expenses and other current assets	420,082	1,121,763
Current assets of discontinued operations		1,328,784
Total current assets	1,336,398	10,758,340
Fixed assets, net	21,689	48,880
Noncurrent assets of discontinued operations		8,661,272
Total assets	1,358,087	19,468,492
Current liabilities
Accounts payable, accrued expenses and other current liabilities	4,820,630	4,023,183
Contingent consideration payable		2,283,806
Current portion of deferred revenue	399,652	568,771
Current portion of long-term debt	5,149,000	13,200,000
Current liabilities of discontinued operations		2,432,374
Total current liabilities	10,369,282	22,508,134
Deferred revenue, noncurrent		161,803
Long-term debt, less current portion		1,407,000
Noncurrent liabilities of discontinued operations		217,083
Total liabilities	10,369,282	24,294,020
Commitments and contingencies (Note 10)
Convertible redeemable preferred stock, par value $0.0001; Series A and Series B, 0 shares issued and outstanding as of December 31, 2023 and 2022 (Note 11)
Stockholders’ deficit
Common stock, par value $0.0001; 150,000,000 shares authorized, 517,605 and 230,140, issued and outstanding as of December 31, 2023 and 2022, respectively	52	23
Additional paid-in capital	164,583,630	160,207,804
Accumulated other comprehensive income	227,000	347,100
Accumulated deficit	(179,144,015)	(167,565,846)
Total stockholders’ deficit	(9,011,195)	(4,825,528)
Total liabilities and stockholders’ deficit	1,358,087	19,468,492
Series C Preferred Stock
Stockholders’ deficit
Preferred stock, value	3,422,000
Special Voting Preferred Stock
Stockholders’ deficit
Preferred stock, value	$ 1,900,138	$ 2,185,391

About Akerna Corp

Akerna Corp. provides enterprise software solutions that enable regulatory compliance and inventory management in the United States and Canada. The company offers MJ Platform for the cannabis, hemp, and CBD industry; and Leaf Data Systems, a government regulatory software. It also provides consulting services to cannabis industry; business intelligence, data analytics and other software related services; and Last Call Analytics, a retail analytics platform. In addition, the company operates Solo, a seed-to-sale tagging and tracking software platform, and Trellis, a cultivation and compliance software platform. Akerna Corp. was founded in 2010 and is headquartered in Denver, Colorado.

CEO	Ms. Jessica Billingsley
WEBSITE	akerna.com
INDUSTRY	Healthcare Plans
EMPLOYEES	112

Akerna Corp Frequently Asked Questions

What is the ticker symbol for Akerna Corp? What does KERN stand for in stocks?

KERN is the stock ticker symbol of Akerna Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Akerna Corp (KERN)?

As of Thu Apr 25 2024, market cap of Akerna Corp is 776.41 Thousand. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of KERN stock?

You can check KERN's fair value in chart for subscribers.

What is the fair value of KERN stock?

You can check KERN's fair value in chart for subscribers. The fair value of Akerna Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Akerna Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for KERN so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Akerna Corp a good stock to buy?

The fair value guage provides a quick view whether KERN is over valued or under valued. Whether Akerna Corp is cheap or expensive depends on the assumptions which impact Akerna Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for KERN.

What is Akerna Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Apr 25 2024, KERN's PE ratio (Price to Earnings) is -0.07 and Price to Sales (PS) ratio is 0.11. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. KERN PE ratio will change depending on the future growth rate expectations of investors.